An adjunctive therapy in the treatment of accute/chronic inflammatory diseases of the liver or hepatic cirrhosis and various liver disorders including acute and chronic hepatitis, cirrhosis, fatty liver disease, Infectious hepatitis, alcohol-induced liver disease
Silymarin is indicated as adjunctive therapy in the treatment of accute/chronic inflammatory diseases of the liver or hepatic cirrhosis and various liver disorders including
- Acute and chronic hepatitis
- cirrhosis
- fatty liver disease
- Infectious hepatitis
- alcohol-induced liver disease